Astria Therapeutics
ATXS
ATXS
110 hedge funds and large institutions have $523M invested in Astria Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 24 reducing their positions, and 17 closing their positions.
Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
25
Increased
42
Reduced
24
Closed
17
Calls
$631K
Puts
$591K
Net Calls
+$40K
Net Calls Change
+$327K
Top Buyers
| 1 |
FIS
1
FCPM III Services
Naarden,
Netherlands
|
$25.7M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$12.2M |
| 3 |
3
BlackRock
New York
|
$34.8M |
| 4 |
VPC
4
Vestal Point Capital
New York
|
$37.4M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$8.33M |
Top Sellers
| 1 |
VA
1
VR Adviser
New York
|
$22M |
| 2 |
AAA
2
Affinity Asset Advisors
New York
|
$0 |
| 3 |
3
Millennium Management
New York
|
$17.2M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$161K |
| 5 |
5
State Street
Boston,
Massachusetts
|
$12.6M |
